Immunocore Holdings plc — Director's Dealing 2024

Feb 21, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Immunocore Holdings plc (IMCR)
CIK: 0001671927
Period of Report: 2024-02-16

Reporting Person: Di Donato Brian (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-16	Employee Share Option (Right to Buy)	$70.50	A	66746	Acquired	2034-02-15	Ordinary Shares (66746)	Direct

Footnotes

F1: 25% of the shares subject to the option award shall vest on February 16, 2025, and 6.25% of the shares subject to the option award shall vest in quarterly installments thereafter, subject to the Reporting Person's continuous service through each such vesting date.